Bosh sahifa006280 ā¢ KRX
add
GC Biopharma Corp
Yopilish kursi
130Ā 300,00Ā ā©
Kunlik diapazon
130Ā 300,00Ā ā© - 131Ā 900,00Ā ā©
Yillik diapazon
111Ā 800,00Ā ā© - 181Ā 800,00Ā ā©
Bozor kapitalizatsiyasi
1,53Ā trln KRW
OŹ»rtacha hajm
52,41Ā ming
Narx/foyda
20,24
Dividend daromadliligi
1,15%
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (KRW) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 500,26Ā mlrd | 19,86% |
Joriy xarajat | 128,79Ā mlrd | 16,53% |
Sof foyda | 37,99Ā mlrd | 647,75% |
Sof foyda marjasi | 7,59 | 557,23% |
Har bir ulushga tushum | 3,33Ā ming | ā |
EBITDA | 49,78Ā mlrd | 31,92% |
Amaldagi soliq stavkasi | 1,37% | ā |
Balans
Jami aktivlari
Jami passivlari
| (KRW) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 85,61Ā mlrd | 9,63% |
Jami aktivlari | 3,10Ā trln | 13,60% |
Jami passivlari | 1,63Ā trln | 31,54% |
Umumiy kapital | 1,47Ā trln | ā |
Tarqatilgan aksiyalar | 11,41Ā mln | ā |
Narxi/balansdagi bahosi | 1,16 | ā |
Aktivlardan daromad | 2,13% | ā |
Kapitaldan daromad | 2,55% | ā |
Pul aylanmasi
Naqd pulning sof oŹ»zgarishi
| (KRW) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 37,99Ā mlrd | 647,75% |
Operatsiyalardan naqd pul | -3,36Ā mlrd | 89,73% |
Sarmoyadan naqd pul | -62,51Ā mlrd | -431,68% |
Moliyadan naqd pul | 59,04Ā mlrd | -4,65% |
Naqd pulning sof oŹ»zgarishi | -5,41Ā mlrd | -131,64% |
BoŹ»sh pul | -31,34Ā mlrd | 55,25% |
Haqida
GC Biopharma is a biopharmaceutical company headquartered in Yongin, South Korea. Wikipedia
Tashkil etilgan
5-okt, 1967
Sayt
Xodimlar soni
2Ā 009
